Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × FED × Cachexia × Clear all

Phase

Status

Sponsor Class

INDUSTRY 12 OTHER 10 FED 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 15 Rare Diseases 2 Neoplasms 2 Neoplasm Metastasis 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Genetic Diseases, Inborn 2 Turcot syndrome 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Respiratory Aspiration 1 Recurrence 1 Radiation Pneumonitis 1 Prostate Cancer Diagnosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Non-Muscle Invasive Bladder Neoplasms 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neuroma, Acoustic 1 Neurologic Manifestations 1 Neurofibromatosis 2 1 Neurofibromatoses 1 Mycosis Fungoides 1 Multiple Myeloma 1 Mental Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01505764 2018-07-17

The Role of Ghrelin in Cancer Cachexia

VA Office of Research and Development

Phase 2 Terminated

10 enrolled 20 charts

Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡